Clinical Trials Browser

INDUSTRY × Observational × tucatinib × Clear all

NCT06961331 2026-01-09

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Breast Neoplasms

NCT05253911 2025-12-04

TRACE

HER2-positive Breast Cancer